December 6, 2024
TOPLINE: Patients with ankylosing spondylitis who were exposed to tumor necrosis factor (TNF) inhibitors had an approximately 30% lower risk for cardiovascular events than those who […]
December 5, 2024
WASHINGTON — Children who have systemic juvenile idiopathic arthritis with lung disease (sJIA-LD) have distinct biomarker profiles that may hold potential in eventually detecting LD earlier […]
December 5, 2024
WASHINGTON — A quality improvement project aimed at reducing racial disparities in juvenile idiopathic arthritis (JIA) led to a modest reduction in the overall clinical Juvenile […]
December 3, 2024
The US Food and Drug Administration (FDA) has approved ustekinumab-kfce (Yesintek) as a biosimilar to ustekinumab (Stelara) for the treatment of Crohn’s disease, ulcerative colitis, plaque […]
November 28, 2024
WASHINGTON — A new guideline for management of lupus nephritis (LN) was unveiled at the American College of Rheumatology (ACR) 2024 Annual Meeting, updating the 2012 […]
November 27, 2024
Disparate views on managing incidental imaging findings made during clinical research — particularly for unclear results — signal a need for standardized guidance, according to recent […]
November 26, 2024
WASHINGTON — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications appear beneficial for people with systemic lupus erythematosus (SLE) and lupus nephritis, two new studies suggest. […]
November 25, 2024
In a nearly unanimous vote at the annual research symposium of the Gout Hyperuricemia and Crystal-Associated Disease Network (G-CAN), members approved a revision to gout remission […]
November 25, 2024
A Mediterranean-inspired plant-based diet improved self-reported measures of gout as well as uric acid levels, a pilot study has found. There hasn’t been a lot of […]